InvestorsHub Logo

The Danish Dude

06/30/21 3:48 AM

#387074 RE: MasterKit #387070

May 12th 2021:

"Meanwhile, manufacturing of vaccine products for compassionate use patients has been and is continuing at the GMP facility in London."

https://www.contractpharma.com/contents/view_breaking-news/2021-05-12/northwest-bio-seeks-gmp-certification-of-sawston-mfg-facility/

January 15th. 2021

NORTHWEST BIOTHERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)

"As described in Note 10 above, we accrued an additional $0.2 million research and development expense related to Advent compassionate use program."

https://www.marketscreener.com/quote/stock/NORTHWEST-BIOTHERAPEUTICS-120787357/news/NORTHWEST-BIOTHERAPEUTICS-nbsp-Management-s-Discussion-and-Analysis-of-Financial-Condition-and-Res-32204487/

And there have been at least a couple of public testemonials to Dr. Ashkans compassionate use of DCVax-L during the last 6 months.